Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Edwin P. Alyea, III"'
Autor:
Jennifer S. Whangbo, Haesook T. Kim, Nikola Mirkovic, Lauren Leonard, Samuel Poryanda, Sophie Silverstein, Soomin Kim, Carol G. Reynolds, Sharmila C. Rai, Kelly Verrill, Michelle A. Lee, Steven Margossian, Christine Duncan, Leslie Lehmann, Jennifer Huang, Sarah Nikiforow, Edwin P. Alyea, III, Philippe Armand, Corey S. Cutler, Vincent T. Ho, Bruce R. Blazar, Joseph H. Antin, Robert J. Soiffer, Jerome Ritz, John Koreth
Publikováno v:
Blood Advances, Vol 3, Iss 17, Pp 2550-2561 (2019)
Abstract: Low-dose interleukin-2 (IL-2) therapy for chronic graft-versus-host disease (cGVHD) generates a rapid rise in plasma IL-2 levels and CD4+CD25+CD127−Foxp3+ regulatory T-cell (CD4Treg) proliferation, but both decrease over time despite cont
Externí odkaz:
https://doaj.org/article/7451b006929a41fca3f95f87e7835ef3
Autor:
Max Jan, Matthew J. Leventhal, Elizabeth A. Morgan, Jordan C. Wengrod, Anwesha Nag, Samantha D. Drinan, Bruce M. Wollison, Matthew D. Ducar, Aaron R. Thorner, Scott Leppanen, Jane Baronas, Jonathan Stevens, William J. Lane, Natasha Kekre, Vincent T. Ho, John Koreth, Corey S. Cutler, Sarah Nikiforow, Edwin P. Alyea, III, Joseph H. Antin, Robert J. Soiffer, Jerome Ritz, R. Coleman Lindsley, Benjamin L. Ebert
Publikováno v:
Blood Advances, Vol 3, Iss 14, Pp 2199-2204 (2019)
Abstract: Immune evasion is a hallmark of cancer and a central mechanism underlying acquired resistance to immune therapy. In allogeneic hematopoietic cell transplantation (alloHCT), late relapses can arise after prolonged alloreactive T-cell control
Externí odkaz:
https://doaj.org/article/dd67bff001a141b5ae1e7eda4fd3a48d
Autor:
Edwin P. Alyea, III, MD, Vincent T. Ho, MD, Brett E. Glotzbecker, MD, Prashant Nageshwar, MD, PhD
Handbook of Stem Cell Transplantation and Cellular Therapy Management provides an evidence-based practical guide for clinicians and practitioners who treat cancer patients with these challenging and innovative techniques. The handbook begins with cha